In 2018, the Advanced Therapies Apprenticeship Community (ATAC) was setup in conjunction with the Medicines Manufacturing Industry Partnership (MMIP) following £1.5m from the Industrial Strategy Challenge Fund (ISCF). The programme now supports 137 apprentices in 37 companies and is addressing the need to develop 300-400 new skilled workers by 2024, as outlined in CGT Catapult’s 2019 Skills Survey. of Oxford Biomedica’s over 700employees are apprentices of the Advanced Therapies Apprenticeship Community % % Oxford Biomedica embracesapprenticeships Oxford Biomedica embraces apprenticeships Case study 4 4 4 4 4 4 0 0 0 Oxford Biomedica embraces apprenticeships Oxford Biomedica’s success and rapid growth forced a reassessment of hiring strategies. Recognising the opportunity that apprenticeships schemes can offer to both employers and employees, they became one of the ATAC founding members. With ATAC’s support, Oxford Biomedica was able to better mobilise human resources to deliver vaccine and advanced therapies during the pandemic. Apprentices now provide 4% of their skilled workforce and will remain an integral part of their ongoing recruitment strategy.